The Food and Drug Administration has cleared the use of the first prescription digital treatment for major depressive disorder. Known as Rejoyn, the treatment is a smartphone app that's designed ...
Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...